INmune Bio, Inc.INMBNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-42.63M
↓ 165% below average
Average (9y)
$-16.12M
Historical baseline
Range
High:$-48868.00
Low:$-42.63M
CAGR
+112.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-42.63M | -43.4% |
| 2023 | $-29.74M | -14.6% |
| 2022 | $-25.95M | +11.0% |
| 2021 | $-29.15M | -138.4% |
| 2020 | $-12.23M | -57.7% |
| 2019 | $-7.76M | +37.7% |
| 2018 | $-12.44M | -1168.1% |
| 2017 | $-981000.00 | -332.2% |
| 2016 | $-227000.00 | -364.5% |
| 2015 | $-48868.00 | - |